100 research outputs found

    In situ synchrotron radiation diffraction investigation of the compression behaviour at 350 °C of ZK40 alloys with addition of CaO and Y

    Get PDF
    The evolution of the microstructure during compression is investigated with in situ synchrotron radiation diffraction in as-cast ZK40, ZK40-2CaO and ZK40-1Y Mg alloys. The specimens were compressed at 350 °C with a strain rate of 10−3 s−1 until 30% deformation. The Y containing alloy showed the highest 0.2% proof strength in compression of 35 MPa at 350 °C which is double that of the ZK40 alloy, while the CaO added alloy shows a moderate increment at 23 MPa. The Y containing alloy shows some work hardening, while the CaO modified and the ZK40 alloys do not show work hardening after yield. Synchrotron radiation diffraction timelines show that continuous and discontinuous dynamic recrystallization occurs during deformation of the ZK40 alloy while a small amount of dynamic recrystallization was observed in the ZK40-1Y alloy. However, dynamic recrystallization was not present in the ZK40-2CaO alloy. SEM-EBSD analysis conducted on the deformed samples shows a significantly high volume fraction of twins in the Y and CaO containing alloys which was absent in the ZK40 alloy. The modified deformation behaviours observed in the CaO and Y containing alloys were attributed to the presence of intermetallic particles found at the grain boundaries and to the role of Ca and Y in stabilising twinning.The authors acknowledge the Deutsches Elektronen-Synchro-tron for the provision of facilities within the framework of proposal I-20130434.RHBacknowledgesUniversityofSãoPaulofor granting the fellowship 'Bolsa Empreendedorismo'

    Microstructure and Mechanical Properties of Ultrafine Quaternary Al-Cu-Si-Mg Eutectic Alloy

    Get PDF
    Copyright: © 2021 by the authors. The microstructure evolution and mechanical properties of quaternary Al-Cu-Si-Mg eutectic alloy prepared via arc melting and suction casting were studied. This alloy exhibits a single endothermic DSC peak with a melting temperature of 509 °C upon heating, suggesting a eutectic reaction. The cast alloy microstructure consisted of four phases, α-Al, Al2Cu (θ ), Si and Al4Cu2Mg8Si7 (Q), in the eutectic cells and also in the nano-scale anomalous eutectic in the intercellular regions. The eutectic cells show different morphologies in different parts of the sample. Well-defined orientation relationships between the α-Al, Al2Cu, and Q phases were found in the eutectic cell centres, while decoupled growth of Q phase occurred at the cell boundaries. The bimodal microstructure exhibits excellent compressive mechanical properties, including a yield strength of 835 ± 35 MPa, a fracture strength of ~1 GPa and a compressive fracture strain of 4.7 ± 1.1%. The high strength is attributed to a combination of a refined eutectic structure and strengthening from multiple hard phases.Engineering and Physical Sciences Research Council (EPSRC) for the financial support on Future Liquid Metal Engineering (LiME) Hub (EP/N007638/1)

    On the influence of solution and ageing treatments on the microstructure of ZK40 alloys modified with Ca, Gd, Nd and y additions

    Get PDF
    Abstract As-cast ZK40 alloys, modified with the addition of CaO, Gd, Nd and Y were investigated. Solution heat treatments were performed based on differential thermal analysis results. The unmodified ZK40 alloy exhibited microstructure with nearly no intermetallic compound but with precipitates formed during the solution treatment. The modified ZK40 alloys exhibited a semi-dissolved network of intermetallic compounds along the grain boundaries and zones of intermetallic compounds within the grains. Interestingly, no precipitates were observed immediately next to the grain boundaries. The energy dispersive X-ray spectroscopy line scans showed an enrichment of Zn and Zr in the regions where the precipitates are found, suggesting that they are Zn-Zr precipitates. The ageing behaviour was compared between the as-cast and the solution treated materials and it was found that apart from the ZK40-Gd, ZK40-Nd and ZK40-Y aged at 200 °C after solution treatment, there is no notable ageing response for the investigated alloys.</jats:p

    Thixomolded AZ91D and MRI153M magnesium alloys and their enhanced corrosion resistance

    Get PDF
    © 2020 The Authors. Materials and Corrosion published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim AZ91D and MRI153M alloys were produced by thixomolding. Their corrosion resistance is significantly higher than that of similar materials produced by ingot or die-casting. A corrosion rate smaller than 0.2 mm/year in 5 wt% NaCl solution is measured for the thixomolded AZ91D alloy. The corrosion behaviour was evaluated using immersion tests, electrochemical impedance spectroscopy, hydrogen evolution, glow discharge optical emission spectroscopy, and atomic emission spectroelectrochemistry. A bimodal microstructure is observed for both alloys, with the presence of coarse primary α-Mg grains, fine secondary α-Mg grains, β-phase, and other phases with a minor volume fraction. The amount of coarse primary α-Mg is significantly higher for the AZ91D compared with the MRI153M. The network of β-phase around the fine secondary α-Mg grains is better established in the thixomolded AZ91D alloy. A combination of several factors such as the ratio of primary to secondary α-Mg grains, localised corrosion or barrier effect due to other phases, as well as regions of preferential dissolution of the α-Mg due to chemical segregation, are thought to be responsible for the high corrosion resistance exhibited by the thixomolded AZ91D and MRI153M.German Ministry of Education and Research; Christian Doppler Societ

    DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Urban South-Asian's are predisposed to early onset of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). There is an urgent need for country specific primary prevention strategies to address the growing burden of cardio-metabolic disease in this population. The aim of this clinical trial is to evaluate whether intensive (3-monthly) lifestyle modification advice is superior to a less-intensive (12 monthly; control group) lifestyle modification advice on a primary composite cardio-metabolic end point in 'at risk' urban subjects aged between 5-40 years.</p> <p>Methods/Design</p> <p>This is an open randomised controlled parallel group clinical trial performed at a single centre in Colombo, Sri-Lanka. A cluster sampling strategy was used to select a large representative sample of subjects aged between 5-40 years at high risk of T2DM and CVD for the intervention study. We have screened 23,298 (males 47% females 53%) healthy subjects for four risk factors: obesity, elevated waist circumference, family history of diabetes and physical inactivity, using a questionnaire and anthropometry. Those with two or more risk-factors were recruited to the intervention trial. We aim to recruit 4600 subjects for the intervention trial. The primary composite cardio-metabolic end point is; new onset T2DM, impaired glucose tolerance, impaired fasting glycaemia, new onset hypertension and albuminuria, following 5 years of intervention. The effect of the intervention on pre-specified secondary endpoints will also be evaluated. The study will be conducted according to good clinical and ethical practice, data analysis and reporting guidelines.</p> <p>Discussion</p> <p>DIABRISK-SL is a large population based trial to evaluate the prevalence of diabetes, pre-diabetes and cardio-metabolic risk factors among young urban Sri-Lankans and the effect of a primary prevention strategy on cardio-metabolic disease end points. This work will enable country specific and regional cardio-metabolic risk scores to be derived. Further if the proposed intervention is successful the results of this study can be translated and implemented as a low-cost primary prevention tool in Sri-Lanka and other low/middle income developing countries.</p> <p>Trial registration</p> <p>The trial is registered with the World Health Organisation and Sri-Lanka clinical trial registry number SLCTR/2008/003</p
    • …
    corecore